Stoop, Thomas F. https://orcid.org/0000-0003-3328-4516
Wu, Y. H. Andrew
Oba, Atsushi https://orcid.org/0000-0002-7315-0830
Ali, Mahsoem https://orcid.org/0000-0002-0511-6323
Messersmith, Wells
Besselink, Marc G.
Burkhart, Richard A.
Wilmink, Johanna W.
Del Chiaro, Marco
,
Feld, Isabel M.
Al-Musawi, Mohammed H.
Jain, Ajay
Saiura, Akio
Sauvanet, Alain
Coppola, Alessandro
Javed, Ammar A.
Groot Koerkamp, Bas
Miller, Braden N.
Hashimoto, Daisuke
Caputo, Damiano
Kleive, Dyre
Sereni, Elisabetta
Kazemier, Geert
Belfiori, Giulio
Ishida, Hirofumi
van Dam, Jacob L.
Dembinski, Jeanne
Akahoshi, Keiichi
Roberts, Keith J.
Tanaka, Kimitaka
Labori, Knut J.
Falconi, Massimo
House, Michael G.
Sugimoto, Motokazu
Tanabe, Minoru
Gotohda, Naoto
Chatzizacharias, Nikolaos
Krohn, Paul S.
Dokmak, Safi
Rodriguez Franco, Salvador
Hirano, Satoshi
Burgdorf, Stefan K.
Crippa, Stefano
Satoi, Sohei
Nguyen, Trang K.
Yamamoto, Tomohisa
Nakamura, Toru
Ushida, Yuta
Bachu, Vismaya
Burns, William R.
Inoue, Yosuke
Takahashi, Yu
Aslami, Zohra
Schulick, Richard D.
He, Jin
Janssen, Boris V.
Pande, Rupaly
Franklin, Oskar
Busch, Olivier R.
Ishida, Hiroyuki
Sugawara, Toshitaka
de Wilde, Roeland F.
Del Chiaro, Marco
Article History
Received: 22 September 2025
Revised: 19 October 2025
Accepted: 14 November 2025
First Online: 12 January 2026
Competing interests
: (1) Marco Del Chiaro has been awarded an industry grant (Haemonetics, Inc.) to conduct a multicenter study to evaluate the prognostic implications of TEG in pancreatic cancer. (2) Marco Del Chiaro is co-principal investigator of a Boston Scientific-sponsored international multicenter study on the use of intraoperative pancreatoscopy in patients with IPMN. (3) Thomas F. Stoop, Johanna W. Wilmink, and Marc G. Besselink received two grants from the Dutch Cancer Society (KWF) and Deltaplan Alvleesklierkanker for the Dutch PREOPANC-4 project on the multidisciplinary management of LAPC, and received another grant from the Dutch Cancer Society (KWF) for the PREOPANC-4 randomised trial to assess the value of surgery in patients with LAPC. (4) Thomas F. Stoop is granted by the Cultuurfonds (Jan de Ruijsscher/Pia Huisman Fonds) and Cancer Centre Amsterdam. (5) Atsushi Oba has been awarded a grant (Bayer Yakuhin, Ltd.) to conduct an observation study to investigate the clinical impact of EOB-MRI. (6) Sohei Satoi discloses receipt of research funding from Nihon Servier, Boston Scientific, and Amino-up co.jp. (7) Johanna W. Wilmink received research grants from Servier, Nordic, and MSD.